Subscribe free

Newsletter

General Surgery

Best Papers in General Surgery

The five that matter, every day.

FreeNo spamOne-click unsubscribe
BMC Surg19 Nov 2023

Sex concordance increased specialist evaluations, potentially addressing under-referral issues in primary hyperparathyroidism.

Investigating primary hyperparathyroidism referrals, a study analyzed 1,100 patients and found that sex concordance (matching patient and practitioner sexes) correlated with increased specialist evaluations. Patients with concordant primary care practitioners had 32% higher odds of endocrinologist evaluation, and those with concordant endocrinologists had a 48%…

J Gastrointest Surg19 Nov 2023

Missed Opportunities: Esophageal Adenocarcinoma Patients with Prior Colonoscopies Lack Timely Esophagogastroduodenoscopy

In the era of widespread colonoscopy, many patients later diagnosed with esophageal adenocarcinoma (EA) had prior screening colonoscopies, presenting missed opportunities for earlier detection. Among 221 referred patients, 49% had prior colonoscopies, yet only 18% had an esophagogastroduodenoscopy (EGD) before EA diagnosis. Most displayed gastroesophageal…

Langenbecks Arch Surg19 Nov 2023

Similar Outcomes in Esophageal Cancer with Different Neoadjuvant Therapies

Comparing neoadjuvant radiochemotherapy protocols for resectable esophageal cancer, this study finds no significant differences in postoperative mortality, complications, or toxicity. Both PF-based and CROSS protocols demonstrate effectiveness and safety, with squamous cell carcinoma and favorable tumor grading independently predicting a higher pathological complete response rate.…

HPB (Oxford)19 Nov 2023

Surviving Biliary Sepsis: Unveiling 90-Day Mortality and Risks

Surviving biliary sepsis: A retrospective study in a cancer center unveils a 30.3% 90-day mortality rate, with factors like metastatic stage, biliary tract tumor compression, and multi-drug resistant bacteria influencing outcomes. Antibiotic de-escalation emerges as a safe strategy, linked with better survival. Beyond organ dysfunctions,…

HPB & Spleen18 Nov 2023

Unveiling Hepatitis D: High Impact on Liver Health and a New Player in the Treatment Game

Hepatitis D Virus (HDV) hitchhikes on Hepatitis B Virus (HBV), impacting 12 to 72 million globally with accelerated liver disease progression. Chronic HDV-HBV infection, deadlier than HBV alone, leads to cirrhosis and hepatocellular carcinoma. Limited awareness hampers diagnosis, but the HBV vaccine offers prevention. Interferon…

J Am Coll Surg18 Nov 2023

Safe and Swift: Short-Stay Left Colectomy for Colon Cancer in the U.S.

Embracing modern surgical trends, this study scrutinizes the safety of brief hospital stays (≤24 hours) after left colectomy for colon cancer. Among 15,745 patients, a mere 1.87% experienced short stays, proving younger, healthier, and with lower morbidity rates than extended stays. Notably, short-stay patients exhibited…

BMC Surg18 Nov 2023

Unlocking Hope for Neuroendocrine Carcinomas: Spheroid Screening Points to DNA Repair Inhibitors

In the quest for effective gastroenteropancreatic neuroendocrine carcinoma treatments, researchers unleashed patient-derived tumor spheroids. A dazzling 16 compounds, notably tyrosyl-DNA phosphodiesterase 1 inhibitors, emerged as fierce warriors against over 75% of these rare tumors. Cytarabine, a standout from the bunch, synergized with standard drugs, intensifying…